K-RAS-Mutationen in nicht-kleinzelligen Lungenkarzinomen (NSCLC) – Ergebnisse aus Routineuntersuchungen in der Lungenklinik Heckeshorn
Christian Boch(Helios Klinikum Emil von Behring), TT Bauer(Helios Klinikum Emil von Behring), Thomas Mairinger(Helios Klinikum Emil von Behring), Jens Kollmeier(Helios Klinikum Emil von Behring), Torsten Blum(MSB Medical School Berlin), A Röth(Helios Klinikum Emil von Behring), W Grüning, D Misch(Helios Klinikum Emil von Behring), Nicolas Schönfeld(Helios Klinikum Emil von Behring)
Cited by 0
Related Papers
Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial
|The Lancet Respiratory Medicine|2021|523
MultiLoc: prediction of protein subcellular localization using N-terminal targeting sequences, sequence motifs and amino acid composition
|Bioinformatics|2006|331
MultiLoc2: integrating phylogeny and Gene Ontology terms improves subcellular protein localization prediction
|BMC Bioinformatics|2009|316
Fatal Outcome in Acute Pancreatitis: Its Occurrence and Early Prediction
|Pancreatology|2001|169
Prävention, Diagnostik, Therapie und Nachsorge des Lungenkarzinoms
|Pneumologie|2010|166